Waiver Agreements in the Pharmaceuticals Industry

84 Contracts & Agreements

Browse by Company

Accelerated Pharma, Inc. (10 contracts)
Acer Therapeutics Inc. (2)
Adamis Pharmaceuticals Corp (1)
Akers Biosciences, Inc. (1)
Akorn (1)
ALIMERA SCIENCES INC (2)
AMYLIN PHARMACEUTICALS INC (1)
Aquestive Therapeutics, Inc. (1)
ARADIGM CORP (1)
AVENUE THERAPEUTICS, INC. (1)
AYTU BIOSCIENCE, INC (5)
Bakhu Holdings, Corp. (1)
BIODELIVERY SCIENCES INTERNATIONAL INC (3)
BioPharmX Corp (1)
Boston Therapeutics, Inc. (2)
Bristol-Myers Squibb (1)
CERAGENIX PHARMACEUTICALS, INC. (1)
Cerecor Inc. (1)
Clever Leaves Holdings Inc. (1)
CNS Pharmaceuticals, Inc. (1)
CUMBERLAND PHARMACEUTICALS INC (1)
Cure Pharmaceutical Holding Corp. (1)
Egalet Corp (1)
Eloxx Pharmaceuticals, Inc. (1)
EYENOVIA, INC. (1)
GB SCIENCES INC (1)
IMAGING3 INC (1)
ISTA PHARMACEUTICALS INC (1)
Jazz Pharmaceuticals plc (4)
Jushi Holdings Inc. (1)
KING PHARMACEUTICALS INC (2)
Medicine Man Technologies, Inc. (1)
Mylan N.V. (1)
Neos Therapeutics, Inc. (4)
Neuralstem, Inc. (3)
Onconova Therapeutics, Inc. (1)
Perrigo (1)
Petros Pharmaceuticals, Inc. (1)
PHARMOS CORP (3)
Phibro Animal Health Corporation (1)
PROVECTUS BIOPHARMACEUTICALS, INC. (1)
RADIENT PHARMACEUTICALS Corp (3)
SYNERGY PHARMACEUTICALS, INC. (5)
Tenzing Acquisition Corp. (1)
Terra Tech Corp. (2)
Tilray, Inc. (1)
Urigen Pharmaceuticals, Inc. (1)
VIVUS INC (1)

Recent Contracts

Form of Waiver and Consent (CNS Pharmaceuticals, Inc., Filed With SEC on July 26, 2024)
Form of Omnibus Waiver and Amendment, dated April 5, 2024, by and between MyMD Pharmaceuticals, Inc. and the investors party thereto (Akers Biosciences, Inc., Filed With SEC on April 8, 2024)
Limited Waiver dated March 12, 2024 between Jushi Holdings Inc. and Roxbury, LP (Jushi Holdings Inc., Filed With SEC on April 1, 2024)
Form of Omnibus Waiver and Amendment, dated March 21, 2024, by and between Petros Pharmaceuticals, Inc. and the investors party thereto (Petros Pharmaceuticals, Inc., Filed With SEC on March 22, 2024)
Waiver and Amendment Agreement, dated as of June 1, 2023, by and between Tilray and HEXO (Tilray, Inc., Filed With SEC on June 2, 2023)
Waiver, dated August (Cerecor Inc., Filed With SEC on August 11, 2022)
Form of Waiver and Right of Participation Letter Agreement (Neuralstem, Inc., Filed With SEC on August 9, 2022)
Consent, Amendment and Waiver, dated March 22, 2022 (Boston Therapeutics, Inc., Filed With SEC on March 24, 2022)
Consent, Amendment and Waiver, dated February 24, 2022 (Boston Therapeutics, Inc., Filed With SEC on March 1, 2022)
Waiver of Certain Rights, dated (Clever Leaves Holdings Inc., Filed With SEC on February 2, 2022)
Waiver Agreement, dated as of January 31, 2022, by and between Palisade Bio, Inc. and Altium Growth Fund, LP (Neuralstem, Inc., Filed With SEC on February 1, 2022)
Waiver Agreement, dated as of November 30, 2021, by and between the Company and SVB (EYENOVIA, INC., Filed With SEC on December 3, 2021)
Waiver and Agreement, dated October 6, 2021, by and between Acer Therapeutics Inc. and Relief Therapeutics Holding AG (Acer Therapeutics Inc., Filed With SEC on October 8, 2021)
Waiver Agreement dated as of September 30, 2021, among Aquestive Therapeutics, Inc., at the Noteholder party thereto (Aquestive Therapeutics, Inc., Filed With SEC on October 6, 2021)
Amendment No. 2 and Waiver to 2018 Revolver, dated as of August 10, 2021, by and among Perrigo Finance Unlimited Company, Perrigo Company plc, JPMorgan Chase Bank, N.A., and the... (Perrigo, Filed With SEC on August 11, 2021)
Waiver Agreement, dated as of July 21, 2021, by and between Palisade Bio, Inc. and Altium Growth Fund, LP (Neuralstem, Inc., Filed With SEC on July 22, 2021)
Consent, Waiver and Sixth Amendment to Facility Agreement, by and among Aytu BioScience, Inc., Neos Therapeutics, Inc., Neos Therapeutics Brands, LLC, Neos Therapeutics, LP, Neos... (Neos Therapeutics, Inc., Filed With SEC on March 22, 2021)
Consent, Waiver and Sixth Amendment to Facility Agreement, by and among Aytu BioScience, Inc., Neos Therapeutics, Inc., Neos Therapeutics Brands, LLC, Neos Therapeutics, LP, Neos... (AYTU BIOSCIENCE, INC, Filed With SEC on March 22, 2021)
Consent and Waiver Agreement, dated February 25, 2021, by and between the Company and Ionic Ventures, LLC (Cure Pharmaceutical Holding Corp., Filed With SEC on February 25, 2021)
Consent, Waiver and Amendment, dated December 16, 2020, between Medicine Man Technologies, Inc. and Dye Capital Cann Holdings, LLC (Medicine Man Technologies, Inc., Filed With SEC on December 23, 2020)
Amendment and Waiver Agreement between Terra Tech Corp. and Michael Nahass, dated December 18, 2020 (Terra Tech Corp., Filed With SEC on December 21, 2020)
Limited Waiver, dated as of December 10, 2020, by and between Neos and the Deerfield Lenders (Neos Therapeutics, Inc., Filed With SEC on December 11, 2020)
Form of Waiver Agreement, dated as of November 19, 2020, by and between Timber Pharmaceuticals, Inc. and the Holders (BioPharmX Corp, Filed With SEC on November 20, 2020)
Limited Waiver, dated as of November 9, 2020, among the Registrant, its subsidiary guarantors, Deerfield Private Design Fund III, L.P. and Deerfield Partners, L.P., as lenders,... (Neos Therapeutics, Inc., Filed With SEC on November 9, 2020)
Form of Waiver Letter, by Tenzing Acquisition Corp. and Reviva Pharmaceuticals, Inc. for the benefit of the Investor named therein (Tenzing Acquisition Corp., Filed With SEC on October 27, 2020)
AGREEMENT, ASSIGNMENT, WAIVER AND ESTOPPEL (Bakhu Holdings, Corp., Filed With SEC on October 1, 2020)
Amendment and Waiver Agreement, dated as of February 14, 2020, by and between Terra Tech and Derek Peterson (Terra Tech Corp., Filed With SEC on February 18, 2020)
Consent and Limited Waiver Agreement, dated November 1, 2019 (AYTU BIOSCIENCE, INC, Filed With SEC on November 7, 2019)
Consent and Limited Waiver Agreement, dated November 1, 2019 (AYTU BIOSCIENCE, INC, Filed With SEC on November 4, 2019)
Consent and Limited Waiver Agreement, dated November 1, 2019 (AYTU BIOSCIENCE, INC, Filed With SEC on November 4, 2019)
Waiver of Blocker dated February 5, 2019 (AYTU BIOSCIENCE, INC, Filed With SEC on February 7, 2019)
Amendment and Waiver No. 6, dated as of November 16, 2018, among Synergy Pharmaceuticals Inc., certain of its subsidiaries, CRG Servicing LLC, as administrative agent and... (SYNERGY PHARMACEUTICALS, INC., Filed With SEC on November 19, 2018)
Waiver Agreement, dated as of November 12, 2018, by and between Avenue Therapeutics, Inc., Fortress Biotech, Inc. and InvaGen Pharmaceuticals Inc (AVENUE THERAPEUTICS, INC., Filed With SEC on November 14, 2018)
Amendment and Waiver No. 5, dated as of November 13, 2018, among Synergy Pharmaceuticals Inc., certain of its subsidiaries, CRG Servicing LLC, as administrative agent and... (SYNERGY PHARMACEUTICALS, INC., Filed With SEC on November 14, 2018)
Waiver No. 4, dated as of November 6, 2018, among Synergy Pharmaceuticals Inc., certain of its subsidiaries, CRG Servicing LLC, as administrative agent and collateral agent and... (SYNERGY PHARMACEUTICALS, INC., Filed With SEC on November 6, 2018)
Amendment and Waiver No. 3, dated as of October 30, 2018, among Synergy Pharmaceuticals Inc., certain of its subsidiaries, CRG Servicing LLC, as administrative agent and... (SYNERGY PHARMACEUTICALS, INC., Filed With SEC on October 31, 2018)
Form of Waiver Agreement, dated October 3, 2018, by and among the Company, the Guarantors and the Waiving Holder(s) (Egalet Corp, Filed With SEC on October 5, 2018)
Form of Waiver No 2 dated as of June 12, 2018 (SYNERGY PHARMACEUTICALS, INC., Filed With SEC on June 13, 2018)
Form of Lock-Up Waiver Agreement (Onconova Therapeutics, Inc., Filed With SEC on April 30, 2018)
TENTH AMENDMENT, WAIVER AND CONSENT (Accelerated Pharma, Inc., Filed With SEC on July 12, 2017)